These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 1333517)
21. Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study. Dutcher JP; Logan T; Gordon M; Sosman J; Weiss G; Margolin K; Plasse T; Mier J; Lotze M; Clark J; Atkins M Clin Cancer Res; 2000 Sep; 6(9):3442-50. PubMed ID: 10999727 [TBL] [Abstract][Full Text] [Related]
22. Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma. Grem JL; Jordan E; Robson ME; Binder RA; Hamilton JM; Steinberg SM; Arbuck SG; Beveridge RA; Kales AN; Miller JA J Clin Oncol; 1993 Sep; 11(9):1737-45. PubMed ID: 8355041 [TBL] [Abstract][Full Text] [Related]
23. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy. Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276 [TBL] [Abstract][Full Text] [Related]
24. Preclinical and clinical study results of the combination of paclitaxel and 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer. Klaassen U; Harstrick A; Wilke H; Seeber S Semin Oncol; 1996 Feb; 23(1 Suppl 1):44-7. PubMed ID: 8629037 [TBL] [Abstract][Full Text] [Related]
25. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study. Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369 [TBL] [Abstract][Full Text] [Related]
26. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991. Wadler S; Atkins M; Karp D; Neuberg D; Haynes H; Dutcher JP Cancer J Sci Am; 1998; 4(4):261-8. PubMed ID: 9689985 [TBL] [Abstract][Full Text] [Related]
27. Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. A phase II study of the ONCOPAZ Cooperative Group. Feliu J; González Barón M; García-Girón C; Espinosa E; García-Alfonso P; Belón J; Blanco E; Garrido P; Ordónez A; Gómez-Navarro J; Zamora P Cancer; 1996 Jul; 78(2):211-6. PubMed ID: 8673994 [TBL] [Abstract][Full Text] [Related]
28. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer. Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328 [TBL] [Abstract][Full Text] [Related]
29. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1. Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717 [TBL] [Abstract][Full Text] [Related]
30. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study. Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913 [TBL] [Abstract][Full Text] [Related]
31. Metastatic carcinoid and islet cell tumours of the pancreas: a phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin. Rougier P; Oliveira J; Ducreux M; Theodore C; Kac J; Droz JP Eur J Cancer; 1991; 27(11):1380-2. PubMed ID: 1660291 [TBL] [Abstract][Full Text] [Related]
32. Weekly high-dose infusional 5-fluorouracil (HD-5-FU) combinations in the treatment of advanced breast cancer: results of phase I/II studies with weekly 24-hour infusion of HD-5-FU plus high-dose folinic acid (FA) alone and in combination with paclitaxel and cisplatin. Klaassen U; Wilke H; Seeber S J Infus Chemother; 1996; 6(3):127-32. PubMed ID: 9229323 [TBL] [Abstract][Full Text] [Related]
33. Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha. Greenblatt MS; Mangalik A; Ferguson J; Elias L Clin Cancer Res; 1995 Jun; 1(6):615-20. PubMed ID: 9816023 [TBL] [Abstract][Full Text] [Related]
34. Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus. Wadler S; Haynes H; Beitler JJ; Hu X; Fell S; Camacho M; Levine B; Wiernik PH Cancer; 1996 Jul; 78(1):30-4. PubMed ID: 8646722 [TBL] [Abstract][Full Text] [Related]
35. Trial of sequential trimetrexate, fluorouracil, and high-dose leucovorin in previously treated patients with gastrointestinal carcinoma. Conti JA; Kemeny N; Seiter K; Goker E; Tong W; André M; Ragusa K; Bertino JR J Clin Oncol; 1994 Apr; 12(4):695-700. PubMed ID: 7512128 [TBL] [Abstract][Full Text] [Related]
36. Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma. Ellerhorst JA; Sella A; Amato RJ; Tu SM; Millikan RE; Finn LD; Banks M; Logothetis CJ Cancer; 1997 Dec; 80(11):2128-32. PubMed ID: 9392335 [TBL] [Abstract][Full Text] [Related]
37. A phase II trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma. Kreuser ED; Hilgenfeld RU; Matthias M; Hoksch B; Boewer C; Oldenkott B; Lenk H; Wiener N; Boese-Landgraf J; Schalhorn A Semin Oncol; 1992 Apr; 19(2 Suppl 4):57-62. PubMed ID: 1553576 [TBL] [Abstract][Full Text] [Related]
38. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma. Patt YZ; Hassan MM; Lozano RD; Brown TD; Vauthey JN; Curley SA; Ellis LM J Clin Oncol; 2003 Feb; 21(3):421-7. PubMed ID: 12560429 [TBL] [Abstract][Full Text] [Related]
39. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775 [TBL] [Abstract][Full Text] [Related]
40. Effective initial therapy of advanced breast cancer with fluorouracil and high-dose, continuous infusion calcium leucovorin. Margolin KA; Doroshow JH; Akman SA; Leong LA; Morgan RJ; Raschko JW; Somlo G; Blevins C J Clin Oncol; 1992 Aug; 10(8):1278-83. PubMed ID: 1634917 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]